secwatch.observer — SEC 8-K summary
======================================

Issuer:     DarioHealth Corp. (DRIO)
CIK:        0001533998
Form:       8-K
Filed at:   2024-06-05T23:59:59+00:00
Accession:  0001104659-24-068526
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

DarioHealth appoints Steven Nelson as CCO; President Richard Anderson departs
-----------------------------------------------------------------------------

- Steven Nelson, formerly CEO of Contigo Health (Premier Inc.), named Chief Commercial Officer effective June 5, 2024.
- Nelson receives $400,000 base salary, annual bonus up to $400,000 tied to GAAP revenue targets (targets redacted).
- Nelson granted time-vesting option for 500,000 shares and performance options for up to 400,000 (2024) and 450,000 shares (2025-2027) vested on revenue milestones.
- President Richard Anderson mutually agreed to step down; no disagreement; will stay as consultant and Advisory Board member.
- Anderson's departure not related to any disagreement with company's operations, policies, or practices.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533998/000110465924068526/0001104659-24-068526-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533998/000110465924068526/tm2416414d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-068526

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer